Lista de obras - Javier Ampuero - Dominio Público Uruguay

Assessing cardiovascular risk in hepatitis C: An unmet need

artículo científico publicado en 2015

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

artículo científico publicado en 2017

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis.

artículo científico publicado en 2016

Deciphering the spectrum of low-grade hepatic encephalopathy in clinical practice

artículo científico publicado en 2014

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

scientific article published on 11 June 2019

Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis

artículo científico publicado en 2018

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

artículo científico publicado en 2017

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

artículo científico publicado en 2018

Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid

artículo científico publicado en 2020

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

artículo científico publicado en 2016

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

artículo científico publicado en 2017

FibroGENE: A gene-based model for staging liver fibrosis

artículo científico publicado en 2015

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

artículo científico publicado en 2015

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.

artículo científico publicado en 2015

Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options

artículo científico publicado en 2016

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

artículo científico publicado en 2013

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

artículo científico publicado en 2016

Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis

artículo científico publicado en 2017

Impact of liver injury on the severity of COVID-19: Systematic Review with Meta-analysis

artículo científico publicado en 2020

Influence of non-alcoholic fatty liver disease on cardiovascular disease

artículo científico publicado en 2012

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

artículo científico publicado en 2016

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

artículo científico publicado en 2016

Metformin inhibits glutaminase activity and protects against hepatic encephalopathy

artículo científico publicado en 2012

Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis

artículo científico publicado en 2015

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.

artículo científico publicado en 2017

Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease

artículo científico publicado en 2012

New technologies - new insights into the pathogenesis of hepatic encephalopathy

artículo científico publicado en 2016

New therapeutic perspectives in non-alcoholic steatohepatitis

artículo científico publicado en 2017

One-step diagnosis. A key tool for the elimination of hepatitis C

artículo científico publicado en 2020

Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy

artículo científico publicado en 2019

Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients

artículo científico publicado en 2016

Pharmacogenetics of ribavirin-induced anemia in hepatitis C.

artículo científico publicado en 2016

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

artículo científico publicado en 2015

Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.

artículo científico

Re: Unsedated colonoscopy: an option for some but not for all

artículo científico publicado en 2012

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

artículo científico publicado en 2017

Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.

artículo científico publicado en 2016

Review article: HCV genotype 3 – the new treatment challenge

artículo científico publicado en 2014

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

artículo científico publicado en 2015

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection

artículo científico publicado en 2016

Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

artículo científico publicado en 2021

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy

artículo científico publicado en 2018

Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat.

artículo científico publicado en 2017

Stanozolol-induced bland cholestasis

artículo científico publicado en 2013

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

scientific article published on 23 October 2018

[Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]

artículo científico publicado en 2013

[Portal thrombosis: beyond liver cirrhosis]

artículo científico publicado en 2014

Lista de obras de Javier Ampuero

Assessing cardiovascular risk in hepatitis C: An unmet need

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis.

Deciphering the spectrum of low-grade hepatic encephalopathy in clinical practice

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

FibroGENE: A gene-based model for staging liver fibrosis

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.

Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis

Impact of liver injury on the severity of COVID-19: Systematic Review with Meta-analysis

Influence of non-alcoholic fatty liver disease on cardiovascular disease

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

Metformin inhibits glutaminase activity and protects against hepatic encephalopathy

Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.

Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease

New technologies - new insights into the pathogenesis of hepatic encephalopathy

New therapeutic perspectives in non-alcoholic steatohepatitis

One-step diagnosis. A key tool for the elimination of hepatitis C

Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy

Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients

Pharmacogenetics of ribavirin-induced anemia in hepatitis C.

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.

Re: Unsedated colonoscopy: an option for some but not for all

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.

Review article: HCV genotype 3 – the new treatment challenge

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection

Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy

Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat.

Stanozolol-induced bland cholestasis

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

[Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]

[Portal thrombosis: beyond liver cirrhosis]